Profiling sugars in the brain and blood related to Alzheimer's disease

Brain and blood N-glycome profiling in Alzheimer's disease

NIH-funded research University of South Florida · NIH-11321443

This study is looking at how certain sugars attached to proteins might be linked to Alzheimer's disease, and it aims to find new markers in the brain and blood that could help us understand the disease better and track its progression in people.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of South Florida NIH-funded
Lab location1 site (Tampa, United States)
Project IDNIH-11321443 on NIH RePORTER

What this research studies

This research investigates the role of N-glycosylation, a process where sugars are added to proteins, in Alzheimer's disease (AD). By analyzing the complete repertoire of N-glycans in both brain and blood samples, the study aims to identify potential biomarkers for AD and understand how changes in these sugars may contribute to the disease's progression. The research will involve large-scale human populations to gather comprehensive data on how these sugar modifications relate to AD pathology and cognitive decline.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals at risk for Alzheimer's disease, such as older adults or those with a family history of dementia.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to the development of reliable biomarkers for early detection and monitoring of Alzheimer's disease.

How similar studies have performed: Previous research has shown promising results in identifying biomarkers related to Alzheimer's disease, suggesting that this approach may yield valuable insights.

Where this research is happening

Tampa, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions age associated neurodegenerative diseaseage associated neurodegenerative disorder
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.